This is in contrast to the reported death of a patient with colon cancer metastatic to lung and liver after ERBB2-CAR therapy caused by tonic signaling through a Herceptin-based third-generation CAR [55]. This evidence concerns the gene ERBB2 and malignant colon neoplasm.